PASINI, Barbara
 Distribuzione geografica
Continente #
NA - Nord America 5800
EU - Europa 4307
AS - Asia 1956
OC - Oceania 85
SA - Sud America 69
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 11
Totale 12253
Nazione #
US - Stati Uniti d'America 5626
CN - Cina 1278
IT - Italia 1039
IE - Irlanda 520
SE - Svezia 437
DE - Germania 422
FR - Francia 411
UA - Ucraina 353
FI - Finlandia 267
GB - Regno Unito 248
KR - Corea 244
CA - Canada 147
PL - Polonia 135
VN - Vietnam 123
AT - Austria 121
JP - Giappone 103
AU - Australia 74
ES - Italia 64
BE - Belgio 63
IN - India 62
NL - Olanda 58
BR - Brasile 36
TR - Turchia 32
DK - Danimarca 31
TW - Taiwan 25
MX - Messico 22
GR - Grecia 20
HK - Hong Kong 19
RO - Romania 19
CH - Svizzera 18
CO - Colombia 18
RU - Federazione Russa 18
NO - Norvegia 15
NZ - Nuova Zelanda 10
CZ - Repubblica Ceca 9
EU - Europa 9
SI - Slovenia 9
TH - Thailandia 9
SA - Arabia Saudita 8
ZA - Sudafrica 8
BA - Bosnia-Erzegovina 7
ID - Indonesia 7
IL - Israele 7
PT - Portogallo 7
AR - Argentina 6
PK - Pakistan 6
EG - Egitto 4
HU - Ungheria 4
MY - Malesia 4
RS - Serbia 4
SG - Singapore 4
UZ - Uzbekistan 4
BD - Bangladesh 3
CL - Cile 3
CR - Costa Rica 3
CY - Cipro 3
EC - Ecuador 3
IR - Iran 3
NG - Nigeria 3
SC - Seychelles 3
SN - Senegal 3
A1 - ???statistics.table.value.countryCode.A1??? 2
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
HN - Honduras 2
IQ - Iraq 2
IS - Islanda 2
LB - Libano 2
MO - Macao, regione amministrativa speciale della Cina 2
MU - Mauritius 2
BO - Bolivia 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
HR - Croazia 1
KE - Kenya 1
KG - Kirghizistan 1
LV - Lettonia 1
MN - Mongolia 1
PE - Perù 1
PG - Papua Nuova Guinea 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 12253
Città #
Beijing 711
Chandler 653
Dublin 514
Houston 510
Ann Arbor 452
Fairfield 380
Torino 279
Woodbridge 260
Villeurbanne 237
Jacksonville 234
Wilmington 223
Ashburn 190
Redwood City 188
Medford 183
Princeton 182
Seattle 169
Hangzhou 157
Warsaw 124
Cambridge 121
Vienna 118
Dearborn 115
Milan 111
Nyköping 96
Pisa 93
Dong Ket 86
Ottawa 78
Boston 68
Fremont 64
Boardman 58
Shanghai 57
New York 44
Guangzhou 43
Verona 39
Brussels 36
Tokyo 35
Nanjing 34
Norwalk 28
Wuhan 26
Turin 24
Honolulu 23
San Diego 20
Chicago 19
Rome 19
Taipei 19
Hefei 18
Rochester 18
Kunming 17
Piemonte 17
Seoul 17
Toronto 16
Barcelona 15
Phoenix 15
Falls Church 14
Mountain View 14
Silver Spring 14
Berlin 13
Buffalo 13
Genova 13
Lachine 13
Paris 13
Changsha 12
Jinan 12
London 12
Athens 11
Bethesda 11
Dallas 11
Lexington 11
Saint Louis 11
Sydney 11
Atlanta 10
Istanbul 10
Laguna Woods 10
Waanrode 10
Bologna 9
Central District 9
Chengdu 9
Hebei 9
Philadelphia 9
Shenyang 9
Zhengzhou 9
Ankara 8
Catanzaro 8
Columbus 8
Lyndhurst 8
Munich 8
Palermo 8
Pavia 8
Xian 8
Duncan 7
Hyderabad 7
Leeds 7
Madison 7
Nanchang 7
Nürnberg 7
Prague 7
San Fernando 7
Sarajevo 7
Southend 7
Tianjin 7
Trieste 7
Totale 7713
Nome #
CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma 922
Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation 451
A case of Feingold type 2 syndrome associated with keratoconus refines keratoconus type 7 locus on chromosome 13q 381
A founder MLH1 mutation in Lynch syndrome families from Piedmont, Italy, is associated with an increased risk of pancreatic tumours and diverse immunohistochemical patterns 328
Array-Comparative Genomic Hybridization Analysis in Fetuses with Major Congenital Malformations Reveals that 24% of Cases Have Pathogenic Deletions/Duplications 263
Bi-allelic MSH6 mutations in a case of early onset multiple primary tumors resembling Lynch and Turcot syndrome 238
Copy number variants analysis in a cohort of isolated and syndromic developmental delay/intellectual disability reveals novel genomic disorders, position effects and candidate disease genes 220
Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer 217
The expanding genetic horizon of primary aldosteronism 213
Frequency of RET mutations in long- and short-segment Hirschsprung disease. 206
PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models 183
Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma. 182
Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. 175
Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) 166
Design of a multiplex ligation-dependent probe amplification assay for SLC20A2: identification of two novel deletions in primary familial brain calcification 166
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives 151
A unique MSH2 exon 8 deletion accounts for a major portion of all mismatch repair gene mutations in Lynch syndrome families of Sardinian origin 149
Differences and homologies of chromosomal alterations within and between breast cancer cell lines: a clustering analysis 143
A fetal case of microphthalmia and limb anomalies with abnormal neuronal migration associated with SMOC1 biallelic variants 143
BRCA1 and BRCA2 germline mutations in early-onset breast carcinoma patients. 138
Ovarian cancer in BRCA1 and BRCA2 gene mutation carriers: Analysis of prognostic factors and survival 129
A syndromic extreme insulin resistance caused by biallelic POC1A mutations in exon 10 128
The association between smoking and cancer incidence in BRCA1 and BRCA2 mutation carriers 126
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations 123
THE EXPRESSION OF LINE1-MET CHIMERIC TRANSCRIPT IDENTIFIES A SUBGROUP OF AGGRESSIVE BREAST CANCERS 118
Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients. 117
A large de novo 9p21.3 deletion in a girl affected by astrocytoma and multiple melanoma. 116
Succinate Dehydrogenase (SDH) D Subunit (SDHD) Inactivation in a Growth-Hormone-Producing Pituitary Tumor: A New Association for SDH? 111
Mutational screening of the RB1 gene in Italian patients with retinoblastoma reveals 11 novel mutations. 106
X-linked Charcot-Marie-Tooth polyneuropathy due to mutation of the connexin-32 gene: revision of our cases of genetic neuropathies and identification of three affected families. 105
Two new cases of double heterozygosity for BRCA1 and BRCA2 gene mutations identified in a cohort of Italian breast and ovarian cancer families. 104
The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers 104
Exploring the link between MORF4L1 and risk of breast cancer 101
Prevalence of Hypokalemia and Primary Aldosteronism in 5100 Patients Referred to a Tertiary Hypertension Unit 96
The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma 94
TERT Promoter Mutations are Associated with Visceral Spreading in Melanoma of the Trunk 94
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. 90
The physical map of the human RET proto-oncogene. 88
Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online. 87
Do Chromosome 17 Centromere Copy Numbers Predict Polysomy? A Fluorescence In Situ Hybridization and Microarray-Based CGH Analysis. 87
Analisi genetica del gene CYP21 in forme non classiche di deficit di 21-beta-idrossilasi 87
Male breast cancer in BRCA1 and BRCA2 mutation carriers: Pathology data from the Consortium of Investigators of Modifiers of BRCA1/2 85
High prevalence of the G101W germline mutation in the CDKN2A (P16ink4a) gene in 62 Italian malignant melanoma families. 84
Congenital Sensorineural Hearing Loss and Inborn Pigmentary Disorders: First Report of Multilocus Syndrome in Piebaldism 83
Management of renal cancer in a contemporary series of patients affected by Von Hippel-Lindau disease. 83
SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the pheochromocytoma-paraganglioma syndromes 83
Mutation detection rates associated with specific selection criteria for BRCA1/2 testing in 1854 high-risk families: A monocentric Italian study 81
A germline mismatch repair mutation possibly leading to a de novo NF1 germline mutation. 78
Liddle syndrome: Review of the literature and description of a new case 78
Association of a new cationic trypsinogen gene mutation (V39A) with chronic pancreatitis in an Italian family 77
The Glu632-Leu633 deletion in cysteine rich domain of Ret induces constitutive dimerization and alters the processing of the receptor protein. 75
Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes 75
Tumori ereditari 74
Fattori genetici predisponenti al carcinoma della mammella 70
CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation. 70
The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. 68
Laparoscopic unilateral adrenalectomy in children for isolated primary pigmented nodular adrenocortical disease (PPNAD): case report and literature review 68
Common breast cancer susceptibility alleles are associated with tumor subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 67
Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers. 67
Treatment of multiple synchronous misdiagnosed renal cell cancers in a young patient affected by a "de novo" Von Hippel-Lindau syndrome 67
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. 66
BRCA1/2 Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic Laboratories 63
Unusual association of pancreatic neuroendocrine tumors and papillary renal cell cancer. 61
Athypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germ line mutation carriers 60
The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and Nck. 60
Radiofrequency Ablation for Renal Cancer in Von Hippel-Lindau Syndrome Patients: A Prospective Cohort Analysis 59
Evaluating breast cancer risk: available models to assess individual breast cancer risk and probability to be a BRCA mutation carrier. 57
DNA polymorphisms and condition for SSCP analysis of the 20 exons of the RET proto-oncogene. 57
Ordering of markers in the pericentromeric region of chromosome 10. 57
A case of medullary thyroid carcinoma, parathyroid focal hyperplasia and pancreatic neuroendocrine tumor without RET and MEN1 mutations 56
Rb and TP53 pathway alterations in sporadic and NF1-related malignant peripheral nerve sheath tumors. 56
Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers 55
Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers 55
Mutation analysis of the MSH6 gene in 52 MLH1/MSH2-negative, HNPCC suspect Italian patients 55
ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes 55
Malignant pheochromocytoma in multiple endocrine neoplasia type 2B syndrome. Case report and review of the literature. 54
Tumours of the ovary. Serous Tumors 54
Incidental tumors in prophylactic oophorectomy specimens from BRCA mutation carriers. 54
Prophylactic thyroidectomy in MEN 2A syndrome. 53
Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature 53
RET activation by germline MEN2A and MEN2B mutations. 52
Analysis of italian BRCA1/2 pathogenic variants identifies a private spectrum in the population from the Bergamo Province in northern Italy 52
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions 51
Tumori Ereditari. 51
I tumori rari. 51
Search for germline mutations by DGGE in Italian von Hippel-Lindau patients. 50
A novel mutation in the SDHD gene responsible for familial paraganglioma. Medical and psychological implications 50
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies 49
A comparison of bilateral breast cancers in BRCA carriers 49
Point mutations affecting the tyrosine kinase domain of the RET proto-oo-oncogene in Hirschsprung patients. 49
Extending the Benign and Malignant Phenotypes Associated with Germline DICER1 Mutations. 48
A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. 47
Le basi molecolari della suscettibilità ereditaria ai tumori. 47
MANAGEMENT OF SMALL RENAL CANCER IN A CONTEMPORARY SERIES OF PATIENTS WITH VON HIPPEL-LINDAU DISEASE. 47
20 novel point mutations and one large deletion in EXT1 and EXT2 genes: Report of diagnostic screening in a large Italian cohort of patients affected by hereditary multiple exostosis. 47
Breast MRI screening in patients with increased familial and/or genetic risk for breast cancer: a preliminary experience. 46
Gastric leiomyoma and hyperplastic polyposis coli in a patient with multiple cutaneous and uterine leiomyomatosis 46
Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutation. 45
Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis 45
Germline CDKN2A mutations in childhood melanoma: A case of melanoma-pancreatic cancer syndrome 45
Totale 10786
Categoria #
all - tutte 18836
article - articoli 0
book - libri 0
conference - conferenze 2127
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20963


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20181517 0000 00 0383 57733380144
2018/20191455 51649865 100146 69181 86170276149
2019/20202420 133106131271 159341 281190 264189208147
2020/20211931 180143175149 190138 17499 162181126214
2021/20221866 888498206 8999 85126 79127374411
2022/20231795 26317673226 231571 2541 0000
Totale 12744